Geode Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$37.5M Buy
3,215,171
+434,347
+16% +$5.06M ﹤0.01% 1582
2025
Q1
$20.7M Buy
2,780,824
+96,318
+4% +$716K ﹤0.01% 1881
2024
Q4
$16.1M Buy
2,684,506
+22,628
+0.9% +$136K ﹤0.01% 2076
2024
Q3
$13.6M Sell
2,661,878
-20,450
-0.8% -$105K ﹤0.01% 2189
2024
Q2
$9.71M Buy
2,682,328
+103,202
+4% +$374K ﹤0.01% 2340
2024
Q1
$8.28M Buy
2,579,126
+55,484
+2% +$178K ﹤0.01% 2437
2023
Q4
$12.4M Buy
2,523,642
+107,763
+4% +$528K ﹤0.01% 2215
2023
Q3
$13.2M Buy
2,415,879
+129,253
+6% +$705K ﹤0.01% 2088
2023
Q2
$15.3M Buy
2,286,626
+70,646
+3% +$474K ﹤0.01% 2036
2023
Q1
$19.6M Buy
2,215,980
+70,337
+3% +$621K ﹤0.01% 1817
2022
Q4
$16.4M Buy
2,145,643
+95,465
+5% +$729K ﹤0.01% 1909
2022
Q3
$14.6M Buy
2,050,178
+19,793
+1% +$141K ﹤0.01% 1972
2022
Q2
$16.4M Buy
2,030,385
+615,970
+44% +$4.98M ﹤0.01% 1895
2022
Q1
$19.6M Sell
1,414,415
-23,947
-2% -$332K ﹤0.01% 1918
2021
Q4
$40.4M Buy
1,438,362
+46,431
+3% +$1.3M ﹤0.01% 1468
2021
Q3
$47.3M Buy
1,391,931
+222,728
+19% +$7.57M 0.01% 1328
2021
Q2
$47.8M Buy
1,169,203
+86,484
+8% +$3.53M 0.01% 1345
2021
Q1
$43.6M Buy
1,082,719
+46,785
+5% +$1.88M 0.01% 1341
2020
Q4
$61.3M Buy
1,035,934
+55,124
+6% +$3.26M 0.01% 968
2020
Q3
$47.7M Buy
980,810
+444,678
+83% +$21.6M 0.01% 942
2020
Q2
$25.9M Buy
536,132
+68,896
+15% +$3.33M 0.01% 1307
2020
Q1
$13M Buy
467,236
+240,540
+106% +$6.68M ﹤0.01% 1576
2019
Q4
$6.78M Sell
226,696
-1,642
-0.7% -$49.1K ﹤0.01% 2269
2019
Q3
$7.06M Buy
+228,338
New +$7.06M ﹤0.01% 2163